Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1993;2(1):43-59.

Tumors of the neuroblastoma group

H Shimada  1
Affiliations
  • PMID: 9420930
Review

Tumors of the neuroblastoma group

H Shimada. Pathology (Phila). 1993.

Abstract

The basic histologic changes associated with the maturational sequences of neuroblastoma tumors are reviewed. The author describes a histopathologic classification system developed for distinguishing favorable and unfavorable prognoses, based on the combination of tumor morphology and patient's age at diagnosis. Also discussed are the results of recent analyses of the biologically significant relationship between histologic findings and molecular markers, such as amplification of the N-myc oncogene and expression of the nerve growth factor receptor gene. Clinical trials involving neuroblastoma tumors are briefly reviewed.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.
    Murray JE, Valli E, Milazzo G, Mayoh C, Gifford AJ, Fletcher JI, Xue C, Jayatilleke N, Salehzadeh F, Gamble LD, Rouaen JRC, Carter DR, Forgham H, Sekyere EO, Keating J, Eden G, Allan S, Alfred S, Kusuma FK, Clark A, Webber H, Russell AJ, de Weck A, Kile BT, Santulli M, De Rosa P, Fleuren EDG, Gao W, Wilkinson-White L, Low JKK, Mackay JP, Marshall GM, Hilton DJ, Giorgi FM, Koster J, Perini G, Haber M, Norris MD. Murray JE, et al. Nat Commun. 2024 Jul 11;15(1):5585. doi: 10.1038/s41467-024-49871-0. Nat Commun. 2024. PMID: 38992040 Free PMC article.
  • 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC. Bleeker G, et al. Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Cochrane Database Syst Rev. 2015. PMID: 26417712 Free PMC article.
  • Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.
    Fusco P, Parisatto B, Rampazzo E, Persano L, Frasson C, Di Meglio A, Leslz A, Santoro L, Cafferata B, Zin A, Cimetta E, Basso G, Esposito MR, Tonini GP. Fusco P, et al. BMC Cancer. 2019 Oct 21;19(1):970. doi: 10.1186/s12885-019-6149-4. BMC Cancer. 2019. PMID: 31638925 Free PMC article.
  • Sam68 is a novel marker for aggressive neuroblastoma.
    Zhao X, Li Z, He B, Liu J, Li S, Zhou L, Pan C, Yu Z, Xu Z. Zhao X, et al. Onco Targets Ther. 2013 Dec 2;6:1751-60. doi: 10.2147/OTT.S52643. eCollection 2013. Onco Targets Ther. 2013. PMID: 24324342 Free PMC article.
  • Neuroblastoma treatment in the post-genomic era.
    Esposito MR, Aveic S, Seydel A, Tonini GP. Esposito MR, et al. J Biomed Sci. 2017 Feb 8;24(1):14. doi: 10.1186/s12929-017-0319-y. J Biomed Sci. 2017. PMID: 28178969 Free PMC article. Review.

Substances

LinkOut - more resources